Contact

Write to Us

    Your Name (required)

    Your Email (required)

    Subject

    Your Message

    Contact Us

    Matrix II, unit 1.10
    Science Park 400
    1098 XH Amsterdam
    The Netherlands

    Email: info@panaxea.eu

    Phone No: +31 20 7400 778

    Follow Us on Twitter

    October 29, 2020

    Exploring the Perceptions of the Ageing Experience in Singaporean Older Adults: a Qualitative Study

    October 29, 2020

    Promoting BioPsychoSocial health of older adults using a Community for Successful Ageing program (ComSA) in Singapore: A mixed-methods evaluation

    October 29, 2020

    Understanding the Attitudes of Clinicians and Patients Toward a Self-Management eHealth Tool for Atrial Fibrillation: Qualitative Study

    October 19, 2020

    New book published with chapter of Bert Vrijhoef and Valentina Vodopivec

    New book published with chapter of Bert Vrijhoef and Valentina Vodopivec The book, titled ‘Integrating the Organization of Health Services, Worker Wellbeing and Quality of Care’ introduces the concept of ‘healthy healthcare’ and posits that this new concept is necessary in light of a shortage of healthcare staff in the […]
    October 13, 2020

    Panaxea to investigate cost-effectiveness of innovative stem cell treatment for osteoarthritis

    Panaxea to investigate cost-effectiveness of innovative stem cell treatment for osteoarthritis As part of the international consortium of the AutoCRAT (Automated Cellular Robot-Assisted Technologies, grant no. 874671) project, Panaxea is evaluating the cost-effectiveness of an innovative robot-assisted platform to manufacture stem cells that can be used to treat osteoarthritis (OA) […]
    August 5, 2020

    Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness

    August 5, 2020

    Understanding the Costs of Surgery: A Bottom-Up Cost Analysis of Both a Hybrid Operating Room and Conventional Operating Room

    June 18, 2020

    Early Cost-Effectiveness of Tumor Infiltrating Lymphocytes (TIL) for Second Line Treatment in Advanced Melanoma: A Model-Based Economic Evaluation

    June 18, 2020

    Barriers and Facilitators to Workforce Changes in Integrated Care